COLUMBIA, Md., Jan. 7 /PRNewswire/ -- Martek Biosciences Corporation
(Nasdaq: MATK) announced today that it is presenting at the 20th Annual JP
Morgan H&Q Healthcare Conference. The Conference is being held January 7-10 at
the Westin St. Francis Hotel in San Francisco, California. Martek's CEO, Henry
Linsert, Jr. will be presenting on Wednesday, January 9, 2002 at 11:00 a.m.
PST in the Elizabethan A&B Room.
A live webcast of Mr. Linsert's presentation will be available by
accessing the Healthcare Conference site through
http://php4.eventsdigital.com/events/jpmhq/healthcare2002/index.html .
The presentation will also be archived for approximately 30 days at that site.
Additionally, a slide format of the presentation will be available at Martek's
investor relations website at http://www.martekbio.com/ approximately two
hours after Mr. Linsert's presentation.
Martek Biosciences Corporation develops, manufactures and sells products
from microalgae. The Company's products include: (1) specialty, nutritional
oils for infant formula; (2) nutritional supplements and food ingredients that
may play a beneficial role in promoting mental and cardiovascular health, and
in the development of the eyes and central nervous system in newborns; and (3)
new, powerful fluorescent markers for diagnostics, rapid miniaturized
screening, and gene and protein detection.
CONTACT: Pete Buzy, Chief Financial Officer of Martek Biosciences
Corporation, +1-410-740-0081.
SOURCE Martek Biosciences Corporation
 back to top
Related links:
http://www.martekbio.com
CONTACT:
Pete Buzy, Chief Financial Officer of Martek
Biosciences Corporation, +1-410-740-0081
|
